- Home
- MRVI vs KGEI Comparison
MRVI vs KGEI Comparison
Compare MRVI & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- KGEI
- Stock Information
- Founded
- MRVI 2014
- KGEI 2008
- Country
- MRVI United States
- KGEI United States
- Employees
- MRVI N/A
- KGEI N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- KGEI
- Sector
- MRVI Health Care
- KGEI
- Exchange
- MRVI Nasdaq
- KGEI Nasdaq
- Market Cap
- MRVI 312.4M
- KGEI 254.9M
- IPO Year
- MRVI 2020
- KGEI N/A
- Fundamental
- Price
- MRVI $2.27
- KGEI $6.92
- Analyst Decision
- MRVI Hold
- KGEI Strong Buy
- Analyst Count
- MRVI 10
- KGEI 1
- Target Price
- MRVI $6.84
- KGEI $11.00
- AVG Volume (30 Days)
- MRVI 1.6M
- KGEI 128.3K
- Earning Date
- MRVI 08-06-2025
- KGEI 08-12-2025
- Dividend Yield
- MRVI N/A
- KGEI N/A
- EPS Growth
- MRVI N/A
- KGEI 42.32
- EPS
- MRVI N/A
- KGEI 0.57
- Revenue
- MRVI $241,856,000.00
- KGEI $60,739,000.00
- Revenue This Year
- MRVI N/A
- KGEI $32.19
- Revenue Next Year
- MRVI $10.62
- KGEI $33.24
- P/E Ratio
- MRVI N/A
- KGEI $12.04
- Revenue Growth
- MRVI N/A
- KGEI 20.06
- 52 Week Low
- MRVI $1.67
- KGEI $2.85
- 52 Week High
- MRVI $10.03
- KGEI $9.89
- Technical
- Relative Strength Index (RSI)
- MRVI 54.46
- KGEI 50.25
- Support Level
- MRVI $2.00
- KGEI $6.54
- Resistance Level
- MRVI $2.44
- KGEI $7.48
- Average True Range (ATR)
- MRVI 0.15
- KGEI 0.32
- MACD
- MRVI -0.00
- KGEI -0.03
- Stochastic Oscillator
- MRVI 61.36
- KGEI 40.43
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About KGEI Kolibri Global Energy Inc. Common stock
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.